lopinavir

(redirected from ABT-378)
Also found in: Dictionary, Wikipedia.

lopinavir

 [lo-pin´ah-vir]
an HIV protease inhibitor, an antiviral agent used in combination with ritonavir in the treatment of human immunodeficiency virus infection; administered orally.

lopinavir

/lo·pin·a·vir/ (lo-pin´ah-vir) an antiviral HIV protease inhibitor, used with ritonavir in the treatment of HIV infection.

lopinavir

[lopin′ävir]
an HIV protease inhibitor, an orally administered antiviral agent used in combination with ritonavir in the treatment of human immunodeficiency virus infection.

lopinavir

An antiretroviral protease inhibitor with potent anti-HIV effect in clinical studies.
 
Adverse effects
Headache, diarrhea.
References in periodicals archive ?
Other studies employed PhenoSense HIV to measure resistance to novel protease inhibitors ABT-378 and BMS 232632.
ABT-378 is currently moving into Phase III development.
ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease.
The agreement significantly expands Abbott's antiviral pharmaceutical product portfolio -- which currently includes two HIV PIs: Norvir(R) (ritonavir), approved in 1996, and ABT-378, currently in Phase III development -- to include three nucleoside reverse transcriptase inhibitors (NRTIs) and one non-nucleoside reverse transcriptase inhibitor (NNRTI), medications commonly used for the treatment of HIV and HBV.